Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

First Wave Biopharma Inc (FWBI)

First Wave Biopharma Inc (FWBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
First Wave BioPharma (NASDAQ: FWBI) Makes Significant Progress in Phase 2 SPAN Clinical Trial

Trial Enrollment Completed for Investigational Therapy of Exocrine Pancreatic Insufficiency First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company

FWBI : 2.96 (+4.59%)
Pre-Market Brief: Stocks Mostly Lower Amid Renewed Recession Fears, Weak China GDP Weighs

March S&P 500 futures (ESH23) are trending down -0.33% this morning after three major U.S. benchmark indices shook off early losses and closed higher on Friday as investors assessed the start of the U.S....

ESH23 : 3,957.05s (-0.09%)
JPM : 244.76 (+1.65%)
BAC : 46.46 (+0.87%)
WFC : 74.83 (+1.70%)
C : 68.95 (+0.98%)
MS : 134.99 (+2.51%)
GS : 596.11 (+2.44%)
CFG : 46.77 (+1.41%)
BTBT : 3.99 (-1.48%)
MARA : 24.18 (+6.85%)
RIOT : 11.76 (-3.21%)
AN : 170.05 (+3.15%)
ZyVersa Therapeutics Appoints Three New Board Members

/PRNewswire/ -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa"), a clinical- stage specialty biopharmaceutical company developing first-in-class drugs...

ZVSA : 1.1400 (-0.87%)
FWBI : 2.96 (+4.59%)
First Wave BioPharma, Inc. Announces Private Placement

BOCA RATON, Fla., July 15, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage...

FWBI : 2.96 (+4.59%)
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders

BOCA RATON, Fla., April 29, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a...

FWBI : 2.96 (+4.59%)
First Wave BioPharma Forms Clinical Steering Committee Focused on Advancing Inflammatory Bowel Disease (IBD) Product Portfolio

Committee members include globally renowned experts in gastrointestinal diseases, including ulcerative colitis and Crohn’s disease...

FWBI : 2.96 (+4.59%)
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19

BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a...

FWBI : 2.96 (+4.59%)
First Wave BioPharma to Participate in Maxim’s 2022 Virtual Growth Conference

BOCA RATON, Fla., March 22, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a...

FWBI : 2.96 (+4.59%)
First Wave BioPharma Announces Poster Presentation at the 2022 Digestive Disease Week (DDW) Conference

Poster presentation to feature research involving niclosamide as a potential treatment for mild-to-moderate ulcerative proctitis and ulcerative...

FWBI : 2.96 (+4.59%)
First Wave BioPharma, Inc. Announces Closing of $9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

BOCA RATON, Fla., March 02, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (the “Company”), a clinical stage biopharmaceutical...

FWBI : 2.96 (+4.59%)

Barchart Exclusives

S&P Futures Tick Lower Ahead of U.S. PMI Data
December S&P 500 E-Mini futures (ESZ24) are trending down -0.24% this morning as weak Eurozone PMI data cast doubt on the health of the global economy, while investors braced for U.S. business activity data. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar